Bendamustine approved by FDA for chronic lymphocytic leukemia

Article

Bendamustine has been approved by the FDA for the treatment of CLL

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.